Published 1 year ago

Access to chronic disease medication ‘still out of reach for many’: WHO report

Summary by Ground News

New WHO report reviews the effect of the COVID-19 pandemic on access to NCD medicines. People living with cancer, heart diseases, chronic respiratory diseases, diabetes, and other NCDs experienced difficulties in accessing their routine medicines. Report also provides insights and data useful for key stakeholders in the NCD pharmaceutical supply chain.

0 Articles

All

Left

Center

Right

UN News

Access to chronic disease medication ‘still out of reach for many’: WHO report

Although COVID-19 is disappearing from view, access to medicines that treat non-communicable diseases, or NCDs, remain out of reach for millions across the world, said the World Health Organization (WHO) in a new report published on Wednesday.

1 year ago·New York, United States

Read Full Article

The European Times News

Access to chronic disease medication ‘still out of reach for many’: WHO report

Access to NCD Medicines: Emergent Issues During the COVID-19 Pandemic and Key Structural Factors, highlights the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries to both anticipate and mitigate the disruption that has hit medical supply chains. Pandemic shortages During the pandemic, people living with cancer, heart diseases, chronic […]

1 year ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.